• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.生物风险和实验室获得性感染:健康生物技术中不容忽视的现实。
Front Bioeng Biotechnol. 2015 Apr 28;3:56. doi: 10.3389/fbioe.2015.00056. eCollection 2015.
2
Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.改进生物安全和生物安保措施和/或策略,以应对实验室获得性感染和相关风险。
Int J Environ Res Public Health. 2018 Nov 29;15(12):2697. doi: 10.3390/ijerph15122697.
3
[Biosafety risk of laboratory-acquired infection and countermeasures based on human factors].[基于人为因素的实验室获得性感染生物安全风险及对策]
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Aug 10;44(8):1309-1315. doi: 10.3760/cma.j.cn112338-20230214-00075.
4
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.全球生物安全3级和4级实验室实验室感染情况调查。
Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1247-58. doi: 10.1007/s10096-016-2657-1. Epub 2016 May 27.
5
Biosafety of personnel of microbiological laboratories in the context of the Federal Law of the Russian Federation № 492-FZ of December 30, 2020 «On the biological safety of the Russian Federation».《俄罗斯联邦生物安全法》(2020 年 12 月 30 日第 492-FZ 号联邦法)背景下微生物实验室人员的生物安全。
Klin Lab Diagn. 2022 Jul 18;67(7):414-422. doi: 10.51620/0869-2084-2022-67-7-414-422.
6
Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures.循证生物安全:微生物控制措施的原则与有效性综述
Clin Microbiol Rev. 2008 Jul;21(3):403-25. doi: 10.1128/CMR.00014-08.
7
[Employee Safety and Biosafety Applications in Microbiology Laboratories; A Multicenter Evaluation in Turkey].[微生物实验室中的员工安全与生物安全应用;土耳其的多中心评估]
Mikrobiyol Bul. 2020 Jul;54(3):347-367. doi: 10.5578/mb.69634.
8
The hidden face of academic researches on classified highly pathogenic microorganisms.关于高致病性分类微生物学术研究的隐藏面。
Infect Genet Evol. 2015 Jan;29:26-34. doi: 10.1016/j.meegid.2014.10.028. Epub 2014 Nov 7.
9
[Biosafety and biosecurity in the medical laboratory. Update and trends].[医学实验室中的生物安全与生物安保。更新与趋势]
Bacteriol Virusol Parazitol Epidemiol. 2007 Jul-Dec;52(3-4):91-9.
10
Design and Construction of a Biosafety Level 3 Autopsy Laboratory.生物安全三级解剖实验室的设计与建造。
Arch Pathol Lab Med. 2021 Apr 1;145(4):407-414. doi: 10.5858/arpa.2020-0644-SA.

引用本文的文献

1
A framework for biosafety assessment of microbial strains in Biotechnology applications.生物技术应用中微生物菌株生物安全评估框架。
Bioinformation. 2025 May 31;21(5):1158-1162. doi: 10.6026/973206300211158. eCollection 2025.
2
Occupational exposure monitoring of airborne respiratory viruses in outpatient medical clinics.门诊医疗诊所空气中呼吸道病毒的职业暴露监测。
Aerosol Sci Technol. 2024 Oct 23. doi: 10.1080/02786826.2024.2403580.
3
Awareness and adoption of farm biosecurity practices in commercial dairy, pig and poultry farms of Uttar Pradesh (India).印度北方邦商业奶牛场、养猪场和家禽养殖场的农场生物安全实践的认知和采用情况。
Trop Anim Health Prod. 2024 Jul 12;56(6):203. doi: 10.1007/s11250-024-04054-3.
4
Hunting for Answers: Assessing spp. Seroprevalence and Risks in Red Deer and Wild Boar in Central Portugal.寻找答案:评估葡萄牙中部马鹿和野猪体内[物种名称]的血清阳性率及风险
Pathogens. 2024 Mar 8;13(3):242. doi: 10.3390/pathogens13030242.
5
A Systematized Overview of Published Reviews on Biological Hazards, Occupational Health, and Safety.已发表的关于生物危害、职业健康与安全的综述的系统概述。
Saf Health Work. 2023 Dec;14(4):347-357. doi: 10.1016/j.shaw.2023.10.008. Epub 2023 Oct 21.
6
Knowledge, attitude and practice of infection prevention and control precautions among laboratory staff: a mixed-methods systematic review.实验室人员感染预防和控制措施的知识、态度和实践:一项混合方法系统评价。
Antimicrob Resist Infect Control. 2023 Jun 13;12(1):57. doi: 10.1186/s13756-023-01257-5.
7
Risk assessment and bioburden evaluation of Agrobacterium tumefaciens-mediated transient protein expression in plants using the CaMV35S promoter.利用 CaMV35S 启动子评估农杆菌介导的植物瞬时蛋白表达的风险和生物负荷。
BMC Biotechnol. 2023 Jun 7;23(1):14. doi: 10.1186/s12896-023-00782-w.
8
Effectiveness of international virtual training on biorisk management in the context of COVID-19.新冠疫情背景下国际虚拟培训在生物风险管理方面的效果。
Front Public Health. 2022 Oct 11;10:888097. doi: 10.3389/fpubh.2022.888097. eCollection 2022.
9
Safety in Medical Laboratories: Perception and Practice of University Students and Laboratory Workers.医学实验室安全:大学生与实验室工作人员的认知与实践
Appl Biosaf. 2021 Sep;26(Suppl 1):S34-S42. doi: 10.1089/apb.20.0050. Epub 2021 Sep 13.
10
Assessment of the Biorisk Status of Veterinary Laboratories in Southwest Nigeria: Application of the Food and Agriculture Organization Laboratory Mapping Tool-Safety Module.尼日利亚西南部兽医实验室生物风险状况评估:联合国粮食及农业组织实验室地图绘制工具-安全模块的应用
Appl Biosaf. 2020 Dec 1;25(4):232-239. doi: 10.1177/1535676020930130.

本文引用的文献

1
Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease.根据多起马尔堡病毒病疫情计算潜伏期和传播间隔期
BMC Res Notes. 2014 Dec 13;7:906. doi: 10.1186/1756-0500-7-906.
2
Gain-of-function experiments: time for a real debate.功能获得性实验:是时候进行一场真正的辩论了。
Nat Rev Microbiol. 2015 Jan;13(1):58-64. doi: 10.1038/nrmicro3405. Epub 2014 Dec 8.
3
Human Brucella canis Infection and Subsequent Laboratory Exposures Associated with a Puppy, New York City, 2012.2012年纽约市与一只幼犬相关的人类犬种布鲁氏菌感染及后续实验室接触情况
Zoonoses Public Health. 2015 Aug;62(5):407-14. doi: 10.1111/zph.12163. Epub 2014 Nov 1.
4
Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.生物安全三级(BSL-3)实验室的建立:在印度环境中设计、建造、调试和运营该设施时需要考虑的重要标准。
Indian J Med Res. 2014 Aug;140(2):171-83.
5
How the current West African Ebola virus disease epidemic is altering views on the need for vaccines and is galvanizing a global effort to field-test leading candidate vaccines.当前西非埃博拉病毒病疫情如何改变人们对疫苗需求的看法,并促使全球努力对主要候选疫苗进行实地测试。
J Infect Dis. 2015 Feb 15;211(4):504-7. doi: 10.1093/infdis/jiu513. Epub 2014 Sep 14.
6
Fatal meningococcal disease in a laboratory worker--California, 2012.2012 年加利福尼亚州一名实验室工作者感染致命性脑膜炎球菌病。
MMWR Morb Mortal Wkly Rep. 2014 Sep 5;63(35):770-2.
7
Assessment of infectious risk in clinical xenotransplantation: the lessons for clinical allotransplantation.临床异种移植中感染风险的评估:对临床同种异体移植的启示。
Xenotransplantation. 2014 Jul-Aug;21(4):307-8. doi: 10.1111/xen.12118.
8
Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: a call for a science-based discussion.对具有大流行潜力的病原体(如流感病毒)进行功能获得性实验的风险与益处:呼吁开展基于科学的讨论。
mBio. 2014 Aug 1;5(4):e01730-14. doi: 10.1128/mBio.01730-14.
9
A One Health approach to the control of zoonotic vectorborne pathogens.一种控制人畜共患病媒介传播病原体的One Health 方法。
Vet Rec. 2014 Apr 19;174(16):398-402. doi: 10.1136/vr.g2539.
10
Immune control strategies for vaccinia virus-related laboratory-acquired infections.针对痘苗病毒相关实验室获得性感染的免疫控制策略。
Biomed Environ Sci. 2014 Feb;27(2):142-6. doi: 10.3967/bes2014.031.

生物风险和实验室获得性感染:健康生物技术中不容忽视的现实。

Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

机构信息

Department of Veterinary Sciences, Veterinary and Animal Science Center (CECAV), School of Agrarian and Veterinary Sciences, University of Trás-os-Montes e Alto Douro , Vila Real , Portugal.

出版信息

Front Bioeng Biotechnol. 2015 Apr 28;3:56. doi: 10.3389/fbioe.2015.00056. eCollection 2015.

DOI:10.3389/fbioe.2015.00056
PMID:25973418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4412124/
Abstract

Advances and research in biotechnology have applications over a wide range of areas, such as microbiology, medicine, the food industry, agriculture, genetically modified organisms, and nanotechnology, among others. However, research with pathogenic agents, such as virus, parasites, fungi, rickettsia, bacterial microorganisms, or genetic modified organisms, has generated concern because of their potential biological risk - not only for people, but also for the environment due to their unpredictable behavior. In addition, concern for biosafety is associated with the emergence of new diseases or re-emergence of diseases that were already under control. Biotechnology laboratories require biosafety measures designed to protect their staff, the population, and the environment, which may be exposed to hazardous organisms and materials. Laboratory staff training and education is essential, not only to acquire a good understanding about the direct handling of hazardous biological agents but also knowledge of the epidemiology, pathogenicity, and human susceptibility to the biological materials used in research. Biological risk can be reduced and controlled by the correct application of internationally recognized procedures such as proper microbiological techniques, proper containment apparatus, adequate facilities, protective barriers, and special training and education of laboratory workers. To avoid occupational infections, knowledge about standardized microbiological procedures and techniques and the use of containment devices, facilities, and protective barriers is necessary. Training and education about the epidemiology, pathogenicity, and biohazards of the microorganisms involved may prevent or decrease the risk. In this way, the scientific community may benefit from the lessons learned in the past to anticipate future problems.

摘要

生物技术的进步和研究在许多领域都有应用,例如微生物学、医学、食品工业、农业、转基因生物和纳米技术等。然而,对病原体(如病毒、寄生虫、真菌、立克次体、细菌微生物或转基因生物)的研究引起了人们的关注,因为它们具有潜在的生物风险——不仅对人类,而且对环境也有潜在的风险,因为它们的行为是不可预测的。此外,人们对生物安全的关注与新疾病的出现或已经得到控制的疾病的再次出现有关。生物技术实验室需要采取生物安全措施来保护其工作人员、公众和环境免受危险生物和材料的侵害。实验室工作人员的培训和教育至关重要,不仅要对直接处理危险生物制剂有很好的了解,还要了解所研究的生物材料的流行病学、致病性和人类易感性。通过正确应用国际公认的程序,如适当的微生物技术、适当的封闭装置、充足的设施、保护屏障以及对实验室工作人员的特殊培训和教育,可以降低和控制生物风险。为了避免职业感染,必须了解标准化的微生物程序和技术以及使用封闭设备、设施和保护屏障的知识。关于所涉及微生物的流行病学、致病性和生物危害的培训和教育,可以预防或降低风险。通过这种方式,科学界可以从过去的经验中吸取教训,预测未来的问题。